|
Federal
Register Notices > Notice
of Registration - 2005 > Boehringer Ingelheim Chemical
Inc.
FR Doc E5-8082 [Federal Register: December 29, 2005 (Volume 70,
Number 249)] [Notices] [Page 77189] From the Federal Register Online
via GPO Access [wais.access.gpo.gov] [DOCID:fr29de05-81]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated June 8, 2005, and published in the Federal Register
on June 15, 2005, (70 FR 34796), Boehringer Ingelheim Chemical Inc.,
2820 N. Normandy Drive, Petersburg, Virginia 23805, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedules II:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Methadone (9250) |
II |
| Methadone Intermediate (9254) |
II |
| Dextropropoxyphene, bulk (non-dosage forms)
(9273) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed controlled substances
for formulation into finished pharmaceuticals. Subsequent to the
Notice of Application, being published in the Federal Register on June
15, 2005, Boehringer Ingelheim Chemical Inc., requested the surrender
of drug code Levo-alphacetylmethadol (9648) from their registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration
of Boehringer Ingelheim Chemical Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public
interest at this time. DEA has investigated Boehringer Ingelheim
Chemical Inc., to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a review of
the company's background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E5-8082 Filed 12-28-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
